S&P 5007,798.99▲0.7% Nasdaq26,803.03▲0.8% Dow53,839.99▲0.1% Russell 2K3,052.85▲0.2% 10-Yr4.64%−4bp VIX14.63+0.08 WTI$81.19▼2.5% Gold$4,408.20▼0.0% EUR/USD1.153▼0.1% BTC$63,421▲0.0% Nikkei67,524▲0.8%
At close · Thu, Aug 13, 2026
Daily Market Updates.

US Markets

Home›US Markets›Sectors›Eli Lilly nears a new buy point after strong earnings

Eli Lilly nears a new buy point after strong earnings

Thursday, August 13, 2026 · Written up by our desk · Sectors

Obesity-drug leader Eli Lilly (LLY) is approaching a new buy point after a strong quarterly earnings update, according to Yahoo Finance.

The article frames the move as a potential entry setup tied to post-earnings momentum toward a technical buy level, but it does not provide additional specific figures in the text available here.

← Newer storyBerkshire Hathaway accelerates share buybacks, spending $4.5 billion…

More like this

US MarketsFast-food chains expand energy drinks, banking on restaurant repeat buyers
US MarketsTim Cook joins Howard Lutnick at Houston manufacturing plant opening
US MarketsExperts caution against dumping cash on $35,000 credit card debt
US MarketsS&P 500 dividend yield falls to record low near 1%
US MarketsMarc Benioff backs agentic AI amid claims AI will cut tech jobs

Sources

Yahoo FinanceIBD 50 Stocks To Watch: Obesity Drug Giant Eli Lilly Offers New Buy Point

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.